Therefore, it is easy to speculate that different immune-subtypes of HCC could originate from the hepatic parenchyma cells of different differentiation stages and have been kept the labels of specific CK19/GPC3 expression profiling as their normal counterparts. The gene discussed is GPC3; the disease is hepatocellular carcinoma.